Tremfya — Medical Mutual
Crohn’s disease
Initial criteria
- Patient age ≥ 18 years AND
 - Patient meets ONE of the following: tried or currently taking corticosteroids, or contraindication; OR tried one other conventional systemic therapy for Crohn’s disease; OR has enterocutaneous or rectovaginal fistulas; OR had ileocolonic resection
 - Medication is prescribed by or in consultation with a gastroenterologist
 
Reauthorization criteria
- Patient has been established on therapy for at least 6 months AND
 - Patient meets at least ONE: objective beneficial clinical response compared with baseline OR improvement compared with baseline in at least one symptom (e.g., decreased pain, fatigue, stool frequency, blood in stool)
 
Approval duration
initial 6 months; reauth 1 year